Showing results (41-50 of 236) with videos related to
Sort By:
Pageof 24
JAMA|November 9, 1979
Digoxin overdose. Limitations of hemoperfusion-hemodialysis treatmentS E Warren, D D FanestilJournal of Cardiovascular Pharmacology|November 1, 1979
Renal perfusion changes during treatment of essential hypertension: prazosin versus propranololD T O'Connor, R A Preston, E H SassoClinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1982
Human catecholamine storage vesicle proteinsD T O'Connor, R P Frigon, R L SokoloffBrain Research|February 27, 1989
Noradrenergic systems in human cerebellumR E Powers, D T O'Connor, D L PriceNeurobiology of Aging|May 1, 1993
Cerebrospinal fluid chromogranin A is unchanged in Alzheimer dementiaD T O'Connor, M T Kailasam, L J ThalJournal of Hypertension|October 1, 1983
Nadolol: evidence for sympathetic nerve inhibition by a beta blocker in essential hypertensionK N Bernstein, A P Barg, D T O'ConnorKidney International|March 1, 1990
Chromogranin A in uremia: progressive retention of immunoreactive fragmentsR J Hsiao, M S Mezger, D T O'ConnorThe Journal of Clinical Endocrinology and Metabolism|November 1, 1989
Plasma chromogranin-A in primary hyperparathyroidismM S Nanes, D T O'Connor, S J MarxJournal of Cardiovascular Pharmacology|May 1, 1979
Prazosin and renal hemodynamics: arteriolar vasodilation during therapy of essential hypertension in manR A Preston, D T O'Connor, R A StoneJournal of Clinical Pharmacology|April 1, 1982
Preserved renal perfusion during treatment of essential hypertension with the beta blocker nadololD T O'Connor, A P Barg, K L DuchinPageof 24